Inhibition of CysLTR1 or CysLTR2 protects against LPS or ischemia-induced microglial inflammation and brain injury (Shi et al., 2015; Chen F. et al., 2017; Lin et al., 2017). Here, CYSLTR1 is linked to ischemia.